Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Hollema

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
The Journal of Pathology|November 8, 2012
Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAILBodvael Pennarun, Jan H Kleibeuker, Wytske Boersma-van Ek, et al.
International Journal of Oncology|January 13, 2005
Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumorsHenriette J G Arts, Steven de Jong, Harry Hollema, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2013
Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markersJustin K Smit, Hette Faber, Maarten Niemantsverdriet, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 20, 2004
Tissue distribution of the death ligand TRAIL and its receptorsDiana C Spierings, Elisabeth G de Vries, Edo Vellenga, et al.
Annals of Surgical Oncology|November 20, 2009
A critical appraisal of circumferential resection margins in esophageal carcinomaBareld B Pultrum, Judith Honing, Justin K Smit, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patientsCiska Buijs, Pax H B Willemse, E G E de Vries, et al.
Gynecologic Oncology|June 28, 2015
Hormone receptors as a marker of poor survival in epithelial ovarian cancerMichel van Kruchten, Pauline van der Marel, Linda de Munck, et al.
The Journal of Pathology|July 8, 2003
Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomasJan J Koornstra, Jan H Kleibeuker, Caroline M M van Geelen, et al.
Cancer|March 22, 2002
Vulvar melanoma: is there a role for sentinel lymph node biopsy?Joanne A de Hullu, Harry Hollema, Harald J Hoekstra, et al.
Maturitas|January 21, 2015
Stopping ovarian cancer screening in BRCA1/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimensCatheleine M G van Driel, Geertruida H de Bock, Henriette J G Arts, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Pathology|November 8, 2012
Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAILBodvael Pennarun, Jan H Kleibeuker, Wytske Boersma-van Ek, et al.
International Journal of Oncology|January 13, 2005
Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumorsHenriette J G Arts, Steven de Jong, Harry Hollema, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2013
Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markersJustin K Smit, Hette Faber, Maarten Niemantsverdriet, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 20, 2004
Tissue distribution of the death ligand TRAIL and its receptorsDiana C Spierings, Elisabeth G de Vries, Edo Vellenga, et al.
Annals of Surgical Oncology|November 20, 2009
A critical appraisal of circumferential resection margins in esophageal carcinomaBareld B Pultrum, Judith Honing, Justin K Smit, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patientsCiska Buijs, Pax H B Willemse, E G E de Vries, et al.
Gynecologic Oncology|June 28, 2015
Hormone receptors as a marker of poor survival in epithelial ovarian cancerMichel van Kruchten, Pauline van der Marel, Linda de Munck, et al.
The Journal of Pathology|July 8, 2003
Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomasJan J Koornstra, Jan H Kleibeuker, Caroline M M van Geelen, et al.
Cancer|March 22, 2002
Vulvar melanoma: is there a role for sentinel lymph node biopsy?Joanne A de Hullu, Harry Hollema, Harald J Hoekstra, et al.
Maturitas|January 21, 2015
Stopping ovarian cancer screening in BRCA1/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimensCatheleine M G van Driel, Geertruida H de Bock, Henriette J G Arts, et al.
Pageof 14